Atlas Trials

Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients

Clinical trial NCT03203590 · UNKNOWN

Trial details

NCT number
NCT03203590
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
2-year Disease-Free Survival
Start date
2017-09-01
Primary completion
2026-01-01
Enrollment
590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.